STOCK TITAN

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NEW BRUNSWICK, N.J., May 12, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16th. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-goldman-sachs-43rd-annual-global-healthcare-conference-301546045.html

SOURCE Johnson & Johnson

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
US
New Brunswick

About JNJ

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.